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IntRoduCtIon c -Jun N-terminal kinases (JNKs), also known as stressactivated protein kinases, are sub-family of the mitogenactivated protein kinase (MAPK). JNKs can be activated by stimuli such as injury, ischemia, pro-inflammatory signals, and activated JNKs induce cell apoptosis through its downstream targets [1] . Three isoforms of JNKs, JNK1, JNK2 and JNK3, have been reported. JNK1 and JNK2 are ubiquitously distributed in tissues, whereas JNK3 is predominantly restricted to brain, where it is expressed in neurons [2] . In the central nervous system (CNS), JNK isoforms activation has been found to be involved in the ischemia, stroke, and neurodegenerative disease like Alzheimer's disease (AD) and Parkinson's disease (PD) [3] [4] . Therefore, JNKs are considered as potential therapeutic targets for treatment these series diseases [5] . However, emerging evidences support the idea that JNK1, JNK2, and JNK3 possess distinct functions in a condition dependent manner, though sometimes there are [6] [7] [8] . One recent study also demonstrates that JNK isoforms play different roles in optic axotomized induced retinal ganglion cells (RGCs) apoptosis [9] . However, the mechanisms underlying the isoform-specific role of JNKs are not fully understood.
In present study, we firstly investigated the expression of JNK isoforms in the RGCs and also to the stimuli of optic nerve axotomy. Then we examined the survival of axotomized RGCs in JNK1, JNK2 or JNK3 deficient mice to reveal the distinct role of each isoform. To elucidate the mechanisms involved, the downstream targets mediating the isoform-specific role of JNKs were investigated.
MAtERIALS And MEtHodS Ethical Approval
All the animal studies were performed upon the approval from the Institutional Animal Care and Use Committee of Qingdao University. Reagents Antibodies, anti-β tubulin III was purchased from Chemicon (Temecula, Calif, USA); anti-JNK1, JNK2, p53 were from R&D Systems (Minneapolis, MN, USA); anti-JNK3 was from ABGENT (San Diego, CA, USA); anti-Bim, Bax, Puma, Noxa, phosphor-JNK were from Cell signaling (Beverly, USA). Other reagents were from Sigma (St Louis MO, USA). RIPA buffer and protease inhibitor cocktail tablet were from Santa Cruz Biotechnology (Santa Cruz, Calif, USA). Mice and Model Establishment JNK1, JNK2 and JNK3-null mice were from the Jackson Laboratory. The mice were housed under a 12:12-h light dark cycle at 22℃-26℃, with free access to water and food. Totally 18 adult mice of each group, including wild type (WT), JNK1 knockout, JNK2 knockout, JNK3 knockout, were recruited. To create the optic nerve axotomy model, mice were anesthetized by intraperitoneal injection of ketamine (60-80 mg/kg) and Xylazine (10-15 mg/kg). A 0.5 cm incision was made in the skin above the left orbit. The optic nerve was exposed under an operating microscope. Using fine scissors, the optic nerve was cut 1 mm behind the nerve head, avoiding injury to the ophthalmic artery. The vascular integrity of the retina was verified by fundoscopic examination. Antibiotics were given intramuscularly to avoid infection. Six mice were assigned for retina RNA extraction, 6 mice were assigned for retina protein extraction, and 6 mice were assigned for perfusion and subsequent retina immunofluorescence (IF) staining. Immunofluorescence Staining Animals were given a lethal dose of anesthesia and were perfused through the heart with 50 mL cold saline, followed by 50 mL 4% paraformaldehyde. Retinas were dissected from connective tissue, post-fixed overnight and transferred to a 30% sucrose solution overnight. Frozen sections of retina (12 μm) were cut longitudinally on a cryostat and thaw mounted onto coated glass slides.
Using anti-β-tubulin III to label the RGCs and then double stained with anti-JNK1, JNK2, JNK3, antibody to check the expression of them in the RGCs. For the whole-mounted staining, after perfusion and post-fix, the retinas were washed three times in phosphate buffered saline (PBS) with 0.3% Triton X-100 for 10min each, and then blocked in 10% normal goat serum and 0.3% Triton for 1h. Primary mouse antibody against β-tubulin (1:400) was added into the blocking solution and incubated overnight at 4℃. After three 10-minute washes in PBS, retina was incubated with Alexa fluor 555-conjugated secondary antibodies at room temperature for 2h. After three times washes with PBS, the retina was finally mounted onto the slides and slides were subjected to microscopy for RGCs number counting via Image J software. Real-time Polymerase Chain Reaction RNA from optic axotomized retinas was isolated using RNaeasy Mini Kit (QIAGEN, Hilden, Germany). The reverse transcription kit, the assay probes and other related reagents were ordered from ThermoFisher Scientific. The real-time polymerase chain reaction (PCR) procedures were based upon the manual protocol provided by the company and performed on Applied Biosystems 7500. Sequences of primer for the BH3-only member were as following: Statistical Analysis Data were presented as mean±SEM.
The densities of the Western blot bands were normalized to the internal loading controls and then normalized to control plasmids or treatments. Student's t-test was used for two group comparisons, and One-way analysis of variance (ANOVA) was used for multigroup comparisons, followed by appropriate post-hoc tests.
RESuLtS

Expression of JNKs Isoforms in the Mice Retina
It had been proved that JNK1 and JNK2 were expressed ubiquitously and JNK3 is predominantly restricted to the brain where it is expressed in neurons [10] . To investigate the role of JNKs isoforms in the degeneration of optic axotomized RGCs, we checked the expression of JNKs isoforms in mice retina by double IF staining. It was showed that three isoforms of JNKs were all expressed in the mice RGCs, though their location was different. JNK1 and JNK2 were expressed mainly in the cytoplasm ( Figure 1A , 1B), whereas JNK3 was expressed predominantly in the nuclear ( Figure 1C ).
Response of JNKs Isoforms to Optic Nerve Axotomy
JNKs have been showed to participate in the neurodegenerative disorders such as stroke, AD, PD, and neurotrauma [5, 11] .
To determinate involvement of JNKs isoforms in the neurodegeneration, the expression pattern of respective isoform was checked with immunoblotting assay. It was showed that optic nerve axotomy induced moderate augmentation of JNK1 and JNK2 expression one day after injury, which returned to the base level at time point of one week. Comparing with that of JNK1 and JNK2, augmentation of JNK3 was more significant and time-lasting which persisted till 2wk after axotomy ( Figure 2 ).
Deficiency of JNK Affecting the Survival of Axotomized
RGCs in Isoform Specific Manner JNKs had been showed to be involved in the neurodegeneration. However, the distinct role played by each isoform had not been fully elucidated. Targeted JNK isoform knock out provided powerful model to examine the role of each isoform. Herein, we utilized individual isoform deficient mice to check its effect on the survival of optic axotomized RGCs. Two weeks after optic nerve axotomy, the retinas of JNK1, JNK2, and JNK3 gene deficiency mice as well as WT were subjected to β-tubulin III IF staining. The survival RGCs which labeled by β-tubulin III Figure 3A ). There was significantly more survival RGCs in JNK3 deficiency mice, compared with that of JNK1 or JNK2 deficiency mice, as well as WT mice ( Figure 3B ). These results indicated that deficiency of JNK3 isoformspecifically promoted the survival of axotomized RGCs. Considering the expression profile of JNK3, we presumed that it was JNK3 that play the predominant role mediating axotomy induced RGCs apoptosis. Expression of Activated JNKs in the Retinas of Optic Nerve Axotomized JNK Isoform Deficiency Mice JNKs, when stimulated by stress, would be activated through phosphorylation (P-), subsequently the activated JNKs fulfilled its role by phosphorylating its targets [4, 6, 12] . To elucidate the mechanism accounting for the protective effects of JNK3 deficiency, we examined activated JNKs level in three JNK isoform deficiency mice. It was showed that the increased active JNKs level induced by optic nerve axotomy was dramatically attenuated in the JNK3 deficiency mice, but not in JNK1, JNK2 deficiency mice or WT mice ( Figure 4A ). c-Jun is the direct downstream substrate of active JNKs and mediates JNK involved events [13] . So we further explored if there is alternation in the p-c-Jun level in retinas of JNK3 deficiency mice. We found that there was not obvious difference in the p-c-Jun level in JNK3 deficiency mice with that of JNK1 and JNK2, as well as WT ( Figure 4B ). Those results indicate that molecules other than c-Jun might participate JNK3 deficiency induced protective effects.
BH3 Family Expression Profiles in the Optic Axotomized
Retinas of JNKs Isoform Deficiency Mice It had been reported that optic nerve axotomy induced RGCs apoptosis [14] [15] .
Mitochondria mediated apoptosis account for programmed cell death in the neurodegenerative disorders [16] [17] . To illuminate the possible molecules mediating the protective effect of JNK3 deficiency, we screened alternation of the BH3 only family members which were the key mediators of mitochondria mediated apoptosis and were reported to involve JNK activation induced neuron apoptosis. With RT-PCR, we found that mRNA level of Noxa was dramatically down-regulated in the retinas of JNK3 deficient mice, compared with that of JNK1 or JNK2 deficient mice as well as WT mice. But other BH3 only family members, including Bax, puma, did not show significant difference. Though Bim mRNA displayed significant increase after optic nerve axotomy, there was no obvious difference between WT and JNK isoform deficiency mice ( Figure 5A ). To confirm the protein level change of Noxa, we further carried out immunoblotting assay. It was showed that axotomy induced Noxa expression was significantly lower in JNK3 deficiency mice than that of JNK1 or JNK2 deficient mice, as well as WT mice ( Figure 5B ). Besides the proapoptotic molecules, we also check the level of Bcl2, which was anti-apoptotic factor, but we did not found detectable difference (data not showed here). 
Death Receptor Mediated Apoptosis Pathway in the optic
Axotomized Retinas of JNKs Isoform Deficient Mice
Besides mitochondria mediated apoptosis, death receptor mediated apoptosis is also one key alternative pathway [18] [19] . To illustrate whether this pathway also got involved in the JNK3 deficiency induced RGCs protective effects, we examined the expression level of Fas and tumor necrosis factor receptor 1 (TNFR1), two key modulator of death receptor mediated apoptosis. It was found that neither Fas ( Figure 6A ) nor TNFR1 ( Figure 6B ) showed significant difference between JNK3 and JNK1 or JNK2 deficiency mice. This indicated that death receptors mediated pathway might not play the main role in JNK3 deficiency induced effects, though we could not exclude its involvement. Instead, attenuated mitochondria mediated apoptosis predominantly accounted for the neuroprotective effects of JNK3 deficiency, in which Noxa was a key player. dISCuSSIon JNKs, including JNK1, JNK2 and JNK3 three isoforms, have been proved to involve in initiation and progression of variety of diseases through mediating cell apoptosis. JNK activation contributed hypoxia induced cardiac cell line, H9C2, apoptosis [20] . It was reported that JNK activation was involved in hippocampus neurons apoptosis, cognitive impairment of the Aβ (1-42)-injected mouse [21] and morroniside prevented Aβ (1-42)-induced apoptosis [22] . Although involvement of JNK activation in neurodegenerative diseases, such as PD and AD, had been well accepted [3] [4] . However the isoform-specific role and its mechanism are to be elucidated. Using optic nerve injury animal model, we investigated the expression of JNKs in the RGCs and how optic nerve axotomy affected 
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Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com the expression. We also investigated the molecule pathway through which JNK isoforms deficiency rendered protective effect on axotomized RGCs. The results revealed that although all isoforms were expressed in the RGCs, the response of each isoform of JNKs to optic nerve axotomy was different. Up-regulated expression of JNK3 was most predominant, compared with JNK1 and JNK2. Deficiency of JNK3, not JNK1 or JNK2, isoform-specifically promoted survival of axotomized RGCs. Expression of Noxa, a BH3-only member of Bcl-2 family, was significantly deduced in JNK3 deficient mice, indicating Noxa might be a key mediator of JNK3 deficiency induced neuroprotective effects. Expression profile of JNK isoform had been reported previously. JNK1 and JNK2 were expressed ubiquitously and JNK3 is predominantly restricted to the brain where it was expressed in neurons [23] . Nonetheless, localization of each isoform in the retina had not been detailedly addressed. Through double-IF staining, we found that three isoforms of JNK were all expressed in the mice RGCs, but their subcellular localization was different. JNK1 and JNK2 were distributed in the cytoplasm, whereas JNK3 was located in the nucleus and the expression profile of JNK might underlie their distinct functions. Involvement of JNKs in the neurodegenerative diseases was widely acknowledged. But emerging evidences supported the idea that JNK1, JNK2, JNK3 possessed distinct functions in a condition dependent manner, though sometimes there were overlaps [23] . For example, neurogenesis of embryonic stem cell was inhibited by JNK1, but not JNK2 or JNK3, deficiency. It was JNK2, not JNK1 or JNK3, that was responsible for the activation of c-Jun in microglias treated with lipopolysacccharide [6] . It was JNK3 that mainly mediated the phosphorylation of the intracellular domain (AICD) of beta-amyloid protein [9] . To reveal the distinct role of each isoform neurotrauma induced neurodegeneration, we firstly checked the response of JNKs isoform to the optic nerve axotomy. It was showed that expression of all three isoforms was up-regulated at the time point of one day after lesion. However, the amplitude and lasting time of augmentation of each isoform were diversified. Augmentation of JNK1 and JNK2 was moderate and restored to the initial level at one week of transaction. JNK3 expression level increased most dramatically and lasted to two week after optic nerve axotomy. Expression of phosphorylated JNKs was also increased which showed the same expression pattern as that of JNK3. Therefore we presumed that pool of phosphorylated JNKs was mainly contributed by the alteration of JNK3. The different expression profile indicated the distinct role played by each isoform of JNKs in axotomy induced neurodegeneration. This phenotype might be condition-dependent since stimuli of permanent occlusion of middle cerebral artery had no obvious effect on the expression of JNKs isoform [24] . Functional deletion provided a straight strategy to access role of targeted gene. To distinguish the isoform-specific role in neurodegeneration, JNK1, JNK2 and JNK3 individual isoform deficient mice were recruited. We examined the survival number of axotomized RGCs. There was no significant difference in the survival RGCs numbers in JNK1 or JNK2 deficient mice, comparing with that of WT mice. However, the survival RGCs number of JNK3 deficient mice was dramatically increased, which was 2 times higher than that of JNK1, JNK2 deficient mice. This demonstrated that protective effect of JNK3 deficiency was isoform-specific. Consistent with our findings, JNK3 deficiency was reported to protect motor neuron [25] , dopaminergic neurons [26] from axotomy induced apoptosis. On other pathological conditions, such as ischemia, drug induced neurotoxicity, deletion of JNK3 also exhibited neuroprotective effect [27] . The underlying mechanism of JNK3 deficiency in neurodegeneration was controversial, though protective effect was confirmed by our study as well as others. The downstream targets of JNKs in both cytosome and nuclear were reported to be involved. Attenuated c-Jun phosphorylation accounted for the protective effect of JNK3 deficiency in the excitotoxicity and ischemia induced apoptosis. Nonetheless, in axotomy induced facial motor neuron death, the protective effect of JNK3 deficiency was c-Jun phosphorylation independent [25] .
In this study, we did not find obvious different in the phosphorylated c-Jun level in JNK3 and JNK1, JNK2 deficient mice, though the activated JNKs level was dramatically attenuated in JNK3 deficiency mice.
Of the JNKs cytosolic targets, BH3 only family members were the mostly addressed factors mediating the neuroprotective effect of JNK3 deficiency. Bax [25] and Puma [28] , in a condition dependent manner, had been reported to involve in JNK3 deficiency induced anti-apoptotic effects. Using real-time PCR, we screened the expression level of BH3 only family members. We found that expression of Noxa, induced by axotomy, was dramatically down-regulated in the retinas from JNK3 deficient mice, compared with that of JNK1 or JNK2 deficient mice as well as WT mice. But there was no detectable difference in the level of Bim, Bad, Bax, and Puma. This was further conformed by the immunoblotting assay. It had been proved that deficiency of Noxa suppressed axotomyinduced motor neuron death [28] . This was consistent with our observation that down-regulation of Noxa by JNK3 deficiency promoted survival of axotomized RGCs. Bcl2, one member of anti-apoptosis mitochondrial membrane protein, did not show obvious difference between JNK3 deficient mice and JNK1 or JNK2 deficient mice. JNK3 inhibition by its specific shRNA could achieve neuroprotective effect on hippocampus neurons against oxygen and glucose deprivation induced apoptosis, which also emphasized isoform specific role of JNK3 [29] . Death receptor mediated apoptosis was another pathway that involved in neurodegeneration [16, 30] . To reveal whether this pathway also participate the isoform-specific protective effect of JNK3 deficiency, we examined the Fas as well as TNFR1 level. We found that neither Fas nor TNFR1 showed noticeable different in JNK3 deficient mice compared with that of JNK1 or JNK2 deficient mice. The key ligand of death receptor, TNFα, did not show detectable difference either. We presumed that death receptor mediated apoptosis might not be the predominant pathway that rendered the neuroprotective effect of JNK3 deficiency, though we could not exclude its involvement. Instead, given the deduced expression of Noxa, attenuated mitochondria mediated apoptosis might account for the protective effects of JNK3 deficiency.
To sum up, of three isoforms, upregulated expression induced by neurotrauma of JNK3 was most dramatic and time-lasting. Deficiency of JNK3 isoform-specifically promoted survival of axotomized RGCs. This neuroprotective effect was fulfilled through neutralizing Noxa expression, but not death receptor mediated apoptosis pathway. This result would throw light on isoform-specific role played JNKs in neurodegenerative disease. It will help to identify novel targets for the therapeutics of neurotrauma.
